User:Mr. Ibrahem/Sorafenib

Sorafenib, sold under the brand name Nexavar, is a medication used to treat renal cell carcinoma, hepatocellular carcinoma, and certain types of thyroid cancer. It is taken by mouth.

Common side effects include diarrhea, rash, hair loss, infection, rash, and tiredness. Other side effects may include a heart attack, gastrointestinal perforation, liver problems, bleeding, and high blood pressure. Use in pregnancy or breastfeeding may harm the baby. It is a protein kinase inhibitor.

Sorafenib was approved for medical use in the United States in 2005 and Europe in 2006. In the United Kingdom 4 weeks of treatment costs the NHS about £3,600 as of 2021. This amount in the United States costs about 20,200 USD.